Advisor Group’s Kyntra Bio KYNB Stock Holding History

Advisor Group’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$50K	Buy	47 +4	+9%	+$4.08K	﹤0.01%	3412
2019 Q3	$40K	Sell	43 -3	-7%	-$3.29K	﹤0.01%	3540
2019 Q2	$52K	Sell	46 -2	-4%	-$2.19K	﹤0.01%	3329
2019 Q1	$64K	Buy	48 +36	+300%	+$48.8K	﹤0.01%	3204
2018 Q4	$14K	Buy	12 +2	+20%	+$2.25K	﹤0.01%	4020
2018 Q3	$14K	Buy	10 +5	+100%	+$7.7K	﹤0.01%	4078
2018 Q2	$8K	Buy	5 +1	+25%	+$1.3K	﹤0.01%	4175
2018 Q1	$5K	Hold	4	–	–	﹤0.01%	4400
2017 Q4	$5K	Sell	4 -8	-67%	-$10K	﹤0.01%	4391
2017 Q3	$15K	Buy	12 +10	+500%	+$10.5K	﹤0.01%	3728
2017 Q2	$2K	Buy	2 +1	+100%	+$697	﹤0.01%	4505
2017 Q1	$1K	Hold	1	–	–	﹤0.01%	4517
2016 Q4	$1K	Hold	1	–	–	﹤0.01%	4349
2016 Q3	$0	Buy	+1	New	+$471	﹤0.01%	4517

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Advisor Group's KYNB Position: Q4 2019 in Review

Advisor Group increased its Kyntra Bio (KYNB) stake by 9.3% in Q4 2019, buying an estimated $4.08K and bringing the position to 47 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #3412.

Advisor Group first reported a position in KYNB in Q3 2016 and has held it in 14 quarters since. The position peaked at $64K in Q1 2019. 213 funds tracked by Wall St. Rank hold KYNB as of Q4 2019.

Advisor Group held 47 shares of Kyntra Bio worth $50K as of Q4 2019.
Advisor Group bought 4 Kyntra Bio shares in Q4 2019, an estimated $4.08K.
Kyntra Bio made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3412 holding.
Advisor Group first reported a position in Kyntra Bio in Q3 2016 and has held it in 14 quarters since.
Advisor Group's Kyntra Bio position peaked at $64K in Q1 2019.
213 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.